Anti-TNF antibody treatment of Crohn's disease

Por van Deventer, S J H
Publicado em 1999

Anti-tumour necrosis factor therapy in Crohn’s disease: where are we now?

Por van Deventer, S J H
Publicado em 2002

A place for TACE

Por van Deventer, S J H
Publicado em 2002

Small therapeutic molecules for the treatment of inflammatory bowel disease

Por van Deventer, S J H
Publicado em 2002

T cell apoptosis and inflammatory bowel disease

Por Peppelenbosch, M P, van Deventer, S J H
Publicado em 2004

HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis

Por Stokkers, P, Reitsma, P, Tytgat, G, van Deventer, S J H
Publicado em 1999

Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets

Por Hommes, D W, Peppelenbosch, M P, van Deventer, S J H
Publicado em 2003

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

Por van Deventer, S J H, Tami, J A, Wedel, M K
Publicado em 2004

Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Por Huibregtse, I L, van Lent, A U, van Deventer, S J H
Publicado em 2007

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease

Por ten Hove, T, van Montfrans, C, Peppelenbosch, M P, van Deventer, S J H
Publicado em 2002

Prevalence of subclinical anterior uveitis in adult patients with inflammatory bowel disease

Por Verbraak, F, Schreinemachers, M, Tiller, A, van Deventer, S J H, de Smet, M D
Publicado em 2001

Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage

Por Kimmings, A, van Deventer, S J H, Obertop, H, Rauws, E, Huibregtse, K, Gouma, D
Publicado em 2000

Divergent Roles of Tumor Necrosis Factor and Platelet-Activating Factor in Endotoxin-Induced Release of Monocyte Chemoattractant Protein 1 and Macrophage Inflammatory Protein 1β...

Por Dekkers, Pascale E. P., Levi, Marcel, van Deventer, Sander J. H., van der Poll, Tom
Publicado em 1999

Distribution and Kinetics of Lipoprotein-Bound Endotoxin

Por Levels, J. H. M., Abraham, P. R., van den Ende, A., van Deventer, S. J. H.
Publicado em 2001

Role of Endogenous Interleukin-12 in Immune Response to Staphylococcal Enterotoxin B in Mice

Por Lauw, Fanny N., Florquin, Sandrine, Speelman, Peter, van Deventer, Sander J. H., van der Poll, Tom
Publicado em 2001

Erythromycin Inhibits Tumor Necrosis Factor Alpha and Interleukin 6 Production Induced by Heat-Killed Streptococcus pneumoniae in Whole Blood

Por Schultz, Marc J., Speelman, Peter, Zaat, Sebastian, van Deventer, Sander J. H., van der Poll, Tom
Publicado em 1998

Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease

Por Stokkers, P, van Aken, B E, Basoski, N, Reitsma, P, Tytgat, G, van Deventer, S J H
Publicado em 1998

Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts

Por Willemsen, L E M, Koetsier, M A, van Deventer, S J H, van Tol, E A F
Publicado em 2003

Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment

Por Verbon, A, Juffermans, N, Van Deventer, S J H, Speelman, P, Van Deutekom, H, Van Der Poll, T
Publicado em 1999

Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis

Por ten Hove, T, van den Blink, B, Pronk, I, Drillenburg, P, Peppelenbosch, M P, van Deventer, S J H
Publicado em 2002